As I watch my mom's mind give way to Alzheimer's, I've started writing letters to my future self. Scientists say it could ...

Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

Neuroscientists have taken a major step toward detecting Alzheimer’s disease in its earliest stages—long before memory loss ...

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into ...

Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, ...

Alzheimer’s may be driven by more than just plaques—scientists have discovered 200+ hidden proteins that could be quietly harming the brain.

People showing early signs of Alzheimer’s, such as slight changes in thinking and memory, may actually become more sociable, ...

For decades, the story of Alzheimer's research has been dominated by a battle between A-beta and tau amyloids, both of which ...

Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of dementia, a new study says.

AI tool identifies nine dementia types from a single scan with 88% accuracy   Mayo Clinic’s StateViewer doubles diagnostic ...

A commonly prescribed pain medication—gabapentin—often considered a safer alternative to opioids for those who suffer from low back pain is now under scrutiny after being linked to increased risks of ...